
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇧🇪BE · Medicine#813K to 10K
- 🇭🇺HU · Medicine#147500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.8K to 6.5K🎙 ~2x weekly·127 episodes·Last published 2d ago - Monthly Reach
Unique listeners across all episodes (30 days)
3.5K to 13K🇧🇪77%🇭🇺23% - Active Followers
Loyal subscribers who consistently listen
1.4K to 5.2K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 11 epsHost
Recent guests
Recent episodes
Anticipating the Global Cardio-Oncology Summit (GC-OS) 2026
Jun 22, 2026
Unknown duration
Cardio-Oncology Spotlight: Joshua Levenson, A Novel Risk Score for ICI Myocarditis
Jun 8, 2026
9m 26s
Cardio-Oncology Spotlight: Isabella Mahe, A Post-Hoc Analysis of a Randomised, Non-Inferiority Trial (API-CAT)
May 25, 2026
7m 29s
Cardio-Oncology Developments in India
Apr 13, 2026
22m 50s
Cardio-Oncology Spotlight: BTK Inhibitor-Associated Hypertension
Mar 30, 2026
14m 40s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/22/26 | ![]() Anticipating the Global Cardio-Oncology Summit (GC-OS) 2026 | The Global Cardio-Oncology Summit is the flagship annual meeting for anyone interested in this field. This year's meeting will be hosted by the team from Virginia Commonwealth University's Pauley Heart Center. Drs. Wendy Bottinor and Fadi Salloum highlight some of the key themes and distinguishing features of this event. Basic science and nursing components will be included. For more information, go to: https://gcos.ic-os.org/ | — | ||||||
| 6/8/26 | ![]() Cardio-Oncology Spotlight: Joshua Levenson, A Novel Risk Score for ICI Myocarditis✨ | Cardio-OncologyICI Myocarditis+4 | Joshua Levenson | University of Pittsburgh School of MedicineUniversity of Pittsburgh+4 | — | Cardio-OncologyICI Myocarditis+4 | — | 9m 26s | |
| 5/25/26 | ![]() Cardio-Oncology Spotlight: Isabella Mahe, A Post-Hoc Analysis of a Randomised, Non-Inferiority Trial (API-CAT)✨ | cardio-oncologybleeding predictors+3 | Dr. Isabella Mahe | API-CATInternational Cardio-Oncology Society | — | cardio-oncologybleeding+5 | — | 7m 29s | |
| 4/13/26 | ![]() Cardio-Oncology Developments in India✨ | cardio-oncologyhealthcare developments+3 | Dr. Suvro Banerjee | Cardiological Society of IndiaWest Bengal Academy of Echocardiography+1 | KolkataWest Bengal+1 | cardio-oncologycardiology+3 | — | 22m 50s | |
| 3/30/26 | ![]() Cardio-Oncology Spotlight: BTK Inhibitor-Associated Hypertension✨ | BTK InhibitorsHypertension+3 | Dr Robert S. Copeland Halperin | Pennsylvania HospitalNorthwell Health System | — | BTK InhibitorsHypertension+3 | — | 14m 40s | |
| 3/16/26 | ![]() Cardio-Oncology Spotlight: BTK Inhibitors and CV Risks✨ | BTK inhibitorscardiovascular risks+3 | Dr. Emily TomasuloDr. Michael Fradley | University of PennsylvaniaInternational Cardio-Oncology Society+7 | — | BTK inhibitorscardiovascular risk+3 | — | 17m 41s | |
| 3/2/26 | ![]() Heart to Heart: What if Heart Disease Precedes a Cancer Diagnosis?✨ | cardiologycancer treatment+3 | Lee Ramsey | International Cardio-Oncology Society | — | heart diseasecancer diagnosis+3 | — | 29m 18s | |
| 2/16/26 | ![]() Using Imaging in the Early Detection of Amyloidosis✨ | AmyloidosisImaging+3 | Dr. Abuzaid | Ain Shams UniversityCreighton University+4 | Cairo, EgyptOmaha, Nebraska+2 | AmyloidosisImaging+3 | — | 29m 50s | |
| 2/2/26 | ![]() Cardio-Oncology: A View from the Middle East✨ | cardio-oncologyheart failure+3 | Dr. Skouri | IC-OSAUBMC | United Arab EmiratesLebanon | cardio-oncologyheart failure+4 | — | 24m 03s | |
| 1/19/26 | ![]() Not Just Small Adults – What is Different when Managing Pediatric Cancer Survivors✨ | pediatric cancercancer survivorship+3 | Dr. Armstrong | St. Jude FacultyDepartment of Epidemiology and Cancer Control+2 | — | pediatric cancersurvivorship+3 | — | 16m 41s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/5/26 | ![]() Global Cardio-Oncology Summit 2025 Cape Town S. Africa: Reflections✨ | Cardio-OncologyDiabetes+3 | Dr. Singh | Cardio–oncology Society of Southern AfricaInternational Cardio–oncology Society | South AfricaCape Town+1 | Cardio-OncologyDiabetic Cardio-metabolic unit+5 | — | 21m 02s | |
| 12/23/25 | ![]() Heart to Heart: When the Doctor Becomes the Patient✨ | medical trainingcancer treatment+4 | Dr. Alexia Oliver | chemotherapytransplant+1 | — | lymphomaheart failure+6 | — | 21m 57s | |
| 12/22/25 | ![]() Cardio-Oncology Strategies for Today’s Lung Cancer Patient | Dr. James Wilson is a consultant clinical oncologist in the UK who specializes in lung and skin cancers. He works at several London hospitals, including the London Clinic, The Cromwell Hospital, and Leaders in Oncology Care (LOC), and also has an NHS base at University College London Hospital (UCLH). His expertise includes treatments like advanced radiotherapy (such as SABR and CyberKnife), chemotherapy, and immunotherapy, and he is involved in research and clinical trials. | — | ||||||
| 12/8/25 | ![]() Heart to Heart: The Most Beautiful Year of My Life | Francesca Ossani survived breast cancer and cardiovascular complications of her cancer therapy but discovered beauty and hope along the way. She discovered the value of collaborative medical care and the hope of sharing the journey with others. She now continues to spread hope and joy in her volunteer work at a pediatric cancer center. Join us as we hear of her remarkable story of hope and joy in the face of incredible challenges. | — | ||||||
| 11/24/25 | ![]() CV Impacts of CAR-T Therapies: Dr. Saad Mahmood | As part of our 2025 Board Review Course Dr. Mahmood provides insights into the contemporary state of our understanding of CAR T therapies, their CV risk, and management. You can purchase the complete set of review course videos at the link below. This includes modules covering the Management & Detection of Cardiac Dysfunction, Toxicities of Traditional Therapies, Hematology, and Immunotherapy.https://members.ic-os.org/store/viewproduct.aspx?id=26378193 | — | ||||||
| 11/10/25 | ![]() Dr. Michael Fradley: What's Next in Cardio-Oncology? | As part of our 2025 Board review course Dr. Fradley reviews some key articles that promise to shape the future of clinical practice.You can purchase the complete set of review course videos at the link below. This includes modules covering the Management & Detection of Cardiac Dysfunction, Toxicities of Traditional Therapies, Hematology, and Immunotherapy.https://members.ic-os.org/store/viewproduct.aspx?id=26378193 | — | ||||||
| 10/20/25 | ![]() Pioneering Cardio-Oncology in Indonesia | Dr. Novi Tham, President of IC-OS Indonesia inspires us with her account of establishing the first cardio-oncology clinic in her country. She currently serves as cardio-oncology director at Siloam Hospitals Lippo Village. | — | ||||||
| 10/6/25 | ![]() Heart Failure Therapy in Patients with Advanced Cancer: A Randomized Clinical Trial | Markus S. Anker, MD, Department of Cardiology, Charité, Hindenburgdamm 30, 12203 Berlin, Germany. Here the team discusses a recent clinical trial related to cancer patients in the palliative care setting being treated for heart failure. You can read the full article here: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf705/8242490 | — | ||||||
| 9/24/25 | ![]() Heart to Heart: Battling For Health from Rural Southern Africa | Taryn Cox was diagnosed with breast cancer while living in remote parts of southern Africa. Her story of tenacity and courage to get proper care is an inspiration for all of us. | — | ||||||
| 9/3/25 | ![]() Resilient Care: Cardio-Oncology Updates from Ukraine | In this episode we hear an update about the ongoing challenges of working in Ukraine along with the resiliance and productivity of the team there in spite of the circumstances. Dr. Kozhukov serves at Kyiv Medical University and the National Stiencific Center The M.D.Strazhesko Institute of Cardiology. Dr. Nataliia Dovganych serves at The M.D.Strazhesko Institute of Cardiology and Uzhgorod State University. Dr. Eugene Storozynsky, is Professor of Medicine and Oncology, Jefferson Health Enterprise Chief of Cardio-Oncology, Toll Heart and Vascular Institute, Sidney Kimmel Medical College-Thomas Jefferson University. | — | ||||||
| 8/28/25 | ![]() Opportunities and Challenges in Poland: Dr. Sebastian Szmit | We caoght up with IC-OS Poland President Sebastian Szmit at the Multinational Association of Supportive Care in Cancer (MASCC) meeting for a quick update on cardio-oncology developments in Poland. | — | ||||||
| 8/18/25 | ![]() Cardio-Oncology Spotlight: Cardiac MRI, Dr. Olga Toro-Salazar | Dr Olga Toro-Salazar is a Paediatric Cardiologist and founded and directs the cardiovascular MRI and cardio-oncology programmes at Connecticut Children's Medical Center, Connecticut, US. Dr Toro-Salazar's expertise is in advanced echocardiographic techniques and cardiac magnetic resonance imaging (CMRI). They have a special interest in myocardial mechanics and tissue characterisation.In this episode she discusses Cardiac Magnetic Resonance Imaging in the Assessment of Cardiac Injury and Toxicity from Cancer‑Related Chemotherapy.You can view the original webinar in its entirely at the link below:https://www.radcliffecardiology.com/webinars/cardiac-magnetic-resonance-imaging-assessment-cardiac-injury-and-toxicity-cancer-related | — | ||||||
| 8/11/25 | ![]() Heart to Heart: When Heart Health Threatens Continued Cancer Treatment | Amy's treatment was nearly suspended due to cardiovascular complications. Cardio-Oncology intervened allowing her to continue life saving therapy. You don't want to miss her story. Amy explains of herself, "Originally from Lincoln, Nebraska, I’m a proud graduate of the University of Nebraska–Lincoln with a degree in Elementary Education and hold a Master’s from Northwest Missouri State. I’ve been married to my high school sweetheart for 33 years, and we have four amazing kids—two grown and married, plus a 14-year-old and a 12-year-old who keep us on our toes. I’m starting my 27th year of teaching and currently teach 3rd grade in Liberty, Missouri." | — | ||||||
| 8/4/25 | ![]() Navigating Cardiac Risks of Modern Breast Cancer Treatments: Dr. Susan Dent | Dr. Susan Dent is a Medical Oncologist at the Wilmot Cancer Institute, Professor of Medicine and Director of Cardio Oncology at the University of Rochester. She is also President of the International Cardio-Oncology Society. In this podcast she provides a summary of a talk originally presented at the ASCO meeting in 2025. | — | ||||||
| 7/28/25 | ![]() Heart to Heart: A Physician Faces Down Cancer, Her Own | Samantha Siegel, MD is an internal medicine physician with Kaiser Permanente. She explains, "I began my primary care practice with a thorough understanding of advanced disease processes that often result in hospitalization and the type of care people need when they transition back home. Then, I was diagnosed with Hodgkin Lymphoma and underwent over two years of intensive cancer treatment, including an autologous bone marrow transplant. This led me to study integrative medicine and to focus my practice on the evolving field of cancer survivorship." You will be encouraged to hear how she has negotiated her own survivorship as a medical professional. | — | ||||||
Showing 25 of 66
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.
